Novel Cholesterol Drug Disappoints: TRANSLATE-TIMI 70 - Medscape
4/3/2022 12:00:00 AM3 years 1 month ago
by Sue Hughes
by Sue Hughes
An investigational antisense oligonucleotide drug targeting a novel cholesterol pathway showed disappointing results in this phase 2b study.
An investigational drug targeting a novel cholesterol pathway has shown disappointing results in the TRANSLATE-TIMI 70 phase 2b study. Vupanorsen is an antisense oligonucleotide targeting hepatic an… [+8781 chars]
full article...